PHARMACOKINETICS AND MONITORING OF CYCLOSPORINE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION

[1] Andrews W, 1985, Transplantation, V39, P338, DOI 10.1097/00007890-198503000-00033

[2] ATKINSON K, 1983, TRANSPLANT P, V15, P2446

[3] BEVERIDGE T, 1981, CURR THER RES CLIN E, V30, P5

[4] Beveridge T, 1982, CYCLOSPORIN A, P35

[5] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J]. AGENTS AND ACTIONS, 1976, 6 (04): : 468 - 475

[6] Borel JF, 1982, CYCLOSPORINE A, P5

[7] BURCKART G, 1985, TRANSPLANT P, V17, P1172

[8] BURCKART GJ, 1983, DRUG INTEL CLIN PHAR, V17, P446

[9] BURCKART GJ, 1984, CLIN PHARMACY, V3, P243

[10] BURCKART GJ, 1985, THERAPEUTIC DRUG MON

[1] Andrews W, 1985, Transplantation, V39, P338, DOI 10.1097/00007890-198503000-00033

[2] ATKINSON K, 1983, TRANSPLANT P, V15, P2446

[3] BEVERIDGE T, 1981, CURR THER RES CLIN E, V30, P5

[4] Beveridge T, 1982, CYCLOSPORIN A, P35

[5] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J]. AGENTS AND ACTIONS, 1976, 6 (04): : 468 - 475

[6] Borel JF, 1982, CYCLOSPORINE A, P5

[7] BURCKART G, 1985, TRANSPLANT P, V17, P1172

[8] BURCKART GJ, 1983, DRUG INTEL CLIN PHAR, V17, P446

[9] BURCKART GJ, 1984, CLIN PHARMACY, V3, P243

[10] BURCKART GJ, 1985, THERAPEUTIC DRUG MON